These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22834919)

  • 1. The potential prognostic role of cardiovascular autonomic failure in α-synucleinopathies.
    Fanciulli A; Strano S; Colosimo C; Caltagirone C; Spalletta G; Pontieri FE
    Eur J Neurol; 2013 Feb; 20(2):231-5. PubMed ID: 22834919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pure Autonomic Failure.
    Thaisetthawatkul P
    Curr Neurol Neurosci Rep; 2016 Aug; 16(8):74. PubMed ID: 27338613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cardiovascular autonomic failure in the differential diagnosis of α-synucleinopathies.
    Leys F; Wenning GK; Fanciulli A
    Neurol Sci; 2022 Jan; 43(1):187-198. PubMed ID: 34817726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies.
    Norcliffe-Kaufmann L; Kaufmann H; Palma JA; Shibao CA; Biaggioni I; Peltier AC; Singer W; Low PA; Goldstein DS; Gibbons CH; Freeman R; Robertson D;
    Ann Neurol; 2018 Mar; 83(3):522-531. PubMed ID: 29405350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview on pure autonomic failure.
    Pavy-Le Traon A; Foubert-Samier A; Fabbri M
    Rev Neurol (Paris); 2024; 180(1-2):94-100. PubMed ID: 38129276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term trends in myocardial sympathetic innervation and function in synucleinopathies.
    Lamotte G; Holmes C; Wu T; Goldstein DS
    Parkinsonism Relat Disord; 2019 Oct; 67():27-33. PubMed ID: 31621602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Under pressure': is there a link between orthostatic hypotension and cognitive impairment in α-synucleinopathies?
    Udow SJ; Robertson AD; MacIntosh BJ; Espay AJ; Rowe JB; Lang AE; Masellis M
    J Neurol Neurosurg Psychiatry; 2016 Dec; 87(12):1311-1321. PubMed ID: 27613160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unveiling autonomic failure in synucleinopathies: Significance in diagnosis and treatment.
    Clement G; Cavillon G; Vuillier F; Bouhaddi M; Béreau M
    Rev Neurol (Paris); 2024; 180(1-2):79-93. PubMed ID: 38216420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Central autonomic failures].
    Senard JM; Despas F; Pathak A
    Presse Med; 2012 Nov; 41(11):1122-7. PubMed ID: 22898130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pure autonomic failure: a restricted Lewy body synucleinopathy or early Parkinson disease?
    Kaufmann H; Goldstein DS
    Neurology; 2010 Feb; 74(7):536-7. PubMed ID: 20157156
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnosis and management of autonomic failure in neurodegenerative disorders.
    Sambati L; Calandra-Buonaura G; Doria A; Cortelli P
    Eur Neurol; 2015; 73(1-2):126-33. PubMed ID: 25503740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autonomic Dysfunction in the Synucleinopathies.
    Coon EA
    Semin Neurol; 2020 Oct; 40(5):492-501. PubMed ID: 32906169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orthostatic Hypotension: JACC State-of-the-Art Review.
    Freeman R; Abuzinadah AR; Gibbons C; Jones P; Miglis MG; Sinn DI
    J Am Coll Cardiol; 2018 Sep; 72(11):1294-1309. PubMed ID: 30190008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limelight on alpha-synuclein: pathological and mechanistic implications in neurodegeneration.
    Wales P; Pinho R; Lázaro DF; Outeiro TF
    J Parkinsons Dis; 2013; 3(4):415-59. PubMed ID: 24270242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autonomic ganglionic injection of α-synuclein fibrils as a model of pure autonomic failure α-synucleinopathy.
    Wang XJ; Ma MM; Zhou LB; Jiang XY; Hao MM; Teng RKF; Wu E; Tang BS; Li JY; Teng JF; Ding XB
    Nat Commun; 2020 Feb; 11(1):934. PubMed ID: 32071315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of pure autonomic failure: A United States prospective cohort.
    Kaufmann H; Norcliffe-Kaufmann L; Palma JA; Biaggioni I; Low PA; Singer W; Goldstein DS; Peltier AC; Shibao CA; Gibbons CH; Freeman R; Robertson D;
    Ann Neurol; 2017 Feb; 81(2):287-297. PubMed ID: 28093795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moving forward the in vivo diagnosis of the synucleinopathies.
    Vilas D
    Clin Auton Res; 2019 Dec; 29(6):575-576. PubMed ID: 30721384
    [No Abstract]   [Full Text] [Related]  

  • 18. Asymptomatic orthostatic hypotension in synucleinopathies: to treat or not to treat?
    Lenka A; Lamotte G; Beach P
    Clin Auton Res; 2024 Feb; 34(1):25-29. PubMed ID: 38079008
    [No Abstract]   [Full Text] [Related]  

  • 19. Is pure autonomic failure an early marker for Parkinson disease, dementia with Lewy bodies, and multiple system atrophy? And other updates on recent autonomic research.
    Muppidi S; Miglis MG
    Clin Auton Res; 2017 Apr; 27(2):71-73. PubMed ID: 28255741
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuropathological spectrum of synucleinopathies.
    Jellinger KA
    Mov Disord; 2003 Sep; 18 Suppl 6():S2-12. PubMed ID: 14502650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.